Abstract: The present invention relates to a method for treating cancer in a subject using a mTOR inhibitor in combination with a therapeutically effective amount of a modulator of a MNK.
Type:
Application
Filed:
November 11, 2009
Publication date:
November 17, 2011
Applicants:
UNIVERSITY HOSPITAL BASEL, NOVARTIS FORSCHUNGSSTIFTUNG, ZWEIGNIEDERLASSUNG, F RIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEAR
Inventors:
Michal Grzmil, Brian Arthur Hemmings, Adrian Merlo, Pier Jr Morin